Does Peripartum Progesterone Affect IQ?
Based on available evidence, peripartum progesterone exposure does not appear to negatively affect IQ or neurodevelopmental outcomes in children.
Evidence Summary
The most direct evidence comes from a 1978 study that specifically examined this question. Children whose mothers received progesterone supplements during pregnancy showed no evidence of accelerated development at 2 years of age or enhanced intellectual and academic attainment at 16 years of age 1. This study directly assessed developmental milestones and long-term cognitive outcomes, finding no detrimental effects on IQ.
More recent data from 2016 supports these findings. In a follow-up of 989 children from twin pregnancies exposed to progesterone versus placebo, neurophysiological development assessed at 48-60 months using the Ages and Stages Questionnaire (ASQ) actually showed slightly higher mean scores in the progesterone-exposed group (p = 0.03) 2. Among dichorionic twins specifically, progesterone exposure was associated with a decreased risk of low ASQ scores (<10th percentile) with an odds ratio of 0.34 (95% CI, 0.14-0.86) 2.
Clinical Context
What the Guidelines Tell Us
The extensive guidelines on progesterone use for preterm birth prevention 3 focus primarily on efficacy for preventing preterm delivery but do not raise concerns about neurodevelopmental outcomes. The FDA drug label for progesterone 4 lists various adverse reactions but does not include cognitive or developmental effects in children.
Important Caveats
Cardiac considerations: The 2016 follow-up study found an increased odds ratio for cardiac diagnoses in progesterone-exposed children (OR 2.38 in dichorionic twins, 95% CI 1.07-5.30), though this was not related to IQ 2. This warrants monitoring but is separate from cognitive outcomes.
ADHD concerns: A 2025 study found no significant association between maternal progesterone use and ADHD risk overall, though continuous use throughout all trimesters showed a trend that may warrant further investigation 5.
Study limitations: The strongest evidence comes from older studies with smaller sample sizes. However, the consistency across different time periods and populations is reassuring.
Bottom Line
Progesterone supplementation during pregnancy, when used for appropriate indications (prior spontaneous preterm birth or short cervical length), does not adversely affect childhood IQ or neurodevelopmental outcomes. If anything, limited evidence suggests neutral to potentially beneficial effects on developmental assessments. The decision to use progesterone should be based on its established benefits for preventing preterm birth in appropriate populations 3, not concerns about cognitive effects in offspring.